
Entheogenix Biosciences enables faster discovery of psychedelic-based medicines for mental health. It uses AI and computational biophysics to identify therapeutic candidates. The company operates in biotech R&D, serving pharmaceutical and research institutions and integrating with standard lab workflows. The approach targets scalable drug discovery in the growing psychedelic medicine market.

Entheogenix Biosciences enables faster discovery of psychedelic-based medicines for mental health. It uses AI and computational biophysics to identify therapeutic candidates. The company operates in biotech R&D, serving pharmaceutical and research institutions and integrating with standard lab workflows. The approach targets scalable drug discovery in the growing psychedelic medicine market.